Acute platelet inhibition with abciximab does not reduce in-stent restenosis.
Malik
I
I
Poullis
M
M
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000990:Antithrombin III; D001777:Blood Coagulation / Q000187:drug effects; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D010447:Peptide Hydrolases / Q000097:blood; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011516:Prothrombin / Q000032:analysis
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; C046193:antithrombin III-protease complex; D000990:Antithrombin III; D011516:Prothrombin; D010447:Peptide Hydrolases; D000077284:Abciximab